Microbial contamination of clinical islet transplant preparations is associated with very low risk of infection.

The impact of bacterial colonization on graft success after total pancreatectomy with autologous islet transplantation: considerations for early definitive surgical intervention. Clin Transplant (2016) 0.76

Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method. Transplant Direct (2016) 0.75

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

Automated method for isolation of human pancreatic islets. Diabetes (1988) 8.23

Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86

Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36

Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol (2005) 2.00

Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation (2007) 1.22

Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation (2010) 1.06

Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. Transplant Proc (1992) 1.01

Current indications for pancreas or islet transplant. Diabetes Obes Metab (2006) 0.98

Detection of microbial contamination during human islet isolation. Cell Transplant (2007) 0.90

The bag method for islet cell infusion. Cell Transplant (2003) 0.90

The bioburden of 590 consecutive human pancreata for islet transplant research. Transplant Proc (1992) 0.90

Microbial surveillance during human pancreatic islet isolation. Transpl Int (2005) 0.87

Microbial surveillance of human islet isolation, in vitro culture, and cryopreservation. Clin Invest Med (1995) 0.85

Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation. Am J Transplant (2011) 0.85

Bacteremia due to transplantation of contaminated cryopreserved pancreatic islets. Cell Transplant (1994) 0.84

Significance of contaminated islet preparations in clinical islet transplantation. Transplant Proc (1994) 0.80

Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation (2010) 4.00

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology (2010) 3.54

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology (2009) 2.51

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation (2013) 2.43

Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol (2007) 2.35

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes (2009) 2.31

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes (2004) 2.22

Cell encapsulation: promise and progress. Nat Med (2003) 2.18

Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis (2010) 1.98

Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98

RNA interference therapy in lung transplant patients infected with respiratory syncytial virus. Am J Respir Crit Care Med (2010) 1.94

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl (2004) 1.80

Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant (2007) 1.78

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76

The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care (2011) 1.66

Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes (2002) 1.61

Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int (2009) 1.58

BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol (2009) 1.53

Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes (2004) 1.46

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant (2005) 1.45

Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation (2015) 1.44

Update on islet transplantation. Cold Spring Harb Perspect Med (2012) 1.40

Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis (2002) 1.37

Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care (2005) 1.35

A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation (2010) 1.35

Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes (2002) 1.32

Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant (2007) 1.27

Current status of clinical islet cell transplantation. Methods Mol Biol (2006) 1.25

Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis (2012) 1.25

Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23

Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes (2006) 1.21

Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation (2004) 1.17

Risk factors for islet loss during culture prior to transplantation. Transpl Int (2008) 1.14

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14

Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant (2007) 1.14

Estimation of pancreas weight from donor variables. Cell Transplant (2006) 1.13

Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation (2006) 1.12

Histologic graft assessment after clinical islet transplantation. Transplantation (2009) 1.12

XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11

Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic β-cells through glycolysis and calcium channels. Endocrinology (2011) 1.11

Current status of pancreatic islet transplantation. Clin Sci (Lond) (2006) 1.11

Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation (2010) 1.10

State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician. Clin Infect Dis (2012) 1.10

A seroprevalence study of west nile virus infection in solid organ transplant recipients. Am J Transplant (2004) 1.09

Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08

Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab (2006) 1.08

Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther (2006) 1.08

The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07

The standardization of pancreatic donors for islet isolations. Transplantation (2005) 1.07

Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng (2005) 1.06

Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation (2010) 1.06

Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients. J Infect Dis (2005) 1.05

Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes (2006) 1.05

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antivir Ther (2009) 1.05

Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol (2013) 1.04

Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03

Surgical aspects of human islet isolation. Islets (2010) 1.03

Circumportal pancreas and islet isolation. Surgery (2008) 1.03

Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02

Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs (2004) 1.01

Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation (2012) 1.00

Permanent haemichorea associated with transient hyperglycemia. BMJ Case Rep (2011) 1.00

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int (2008) 1.00

A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis (2007) 1.00

Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant (2004) 1.00

Risks and side effects of islet transplantation. Curr Diab Rep (2004) 1.00

Beta-cell transplantation for diabetes therapy. Lancet (2008) 0.99

Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis (2003) 0.98

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98

Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation (2007) 0.98

Current indications for pancreas or islet transplant. Diabetes Obes Metab (2006) 0.98

Technical aspects of islet preparation and transplantation. Transpl Int (2003) 0.98

Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats. Xenotransplantation (2003) 0.98